Universe · entity
Rhenman & Partners Asset Management AB
Institutional manager (13F) · CIK 1599882
13F holdings · as of 2026-03-31 · top 50 · reported portfolio $687M
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | BOSTON SCIENTIFIC CORP | $39M | 625,000 |
| 2 | REGENERON PHARMACEUTICALS | $37M | 48,100 |
| 3 | LILLY ELI & CO | $31M | 33,715 |
| 4 | INSMED INC | $26M | 159,760 |
| 5 | CVS HEALTH CORP | $24M | 336,500 |
| 6 | GILEAD SCIENCES INC | $23M | 167,750 |
| 7 | THERMO FISHER SCIENTIFIC INC | $20M | 41,340 |
| 8 | BIOGEN INC | $20M | 109,100 |
| 9 | VERTEX PHARMACEUTICALS INC | $19M | 43,485 |
| 10 | ALIGNMENT HEALTHCARE INC | $19M | 1,053,450 |
| 11 | INTUITIVE SURGICAL INC | $17M | 36,846 |
| 12 | CENCORA INC | $16M | 52,375 |
| 13 | STRYKER CORPORATION | $16M | 47,800 |
| 14 | ABBVIE INC | $16M | 71,575 |
| 15 | VEEVA SYS INC | $15M | 85,300 |
| 16 | MCKESSON CORP | $15M | 16,850 |
| 17 | JAZZ PHARMACEUTICALS PLC | $14M | 75,890 |
| 18 | GUARDANT HEALTH INC | $13M | 145,000 |
| 19 | NEUROCRINE BIOSCIENCES INC | $13M | 100,841 |
| 20 | EDWARDS LIFESCIENCES CORP | $13M | 163,000 |
| 21 | MADRIGAL PHARMACEUTICALS INC | $13M | 24,050 |
| 22 | UNITED HEALTH GROUP INC | $12M | 45,500 |
| 23 | PROCEPT BIOROBOTICS CORP | $12M | 475,000 |
| 24 | BIOMARIN PHARMACEUTICAL INC | $12M | 207,000 |
| 25 | ABBOTT LABORATORIES | $11M | 112,000 |
| 26 | ALNYLAM PHARMACEUTICALS INC | $11M | 34,465 |
| 27 | ROYALTY PHARMA PLC | $11M | 233,000 |
| 28 | AXSOME THERAPEUTICS INC | $11M | 63,800 |
| 29 | NATERA INC | $10M | 51,600 |
| 30 | TENET HEALTHCARE CORP | $10M | 54,000 |
| 31 | ADAPTIVE BIOTECHNOLOGIES COR | $10M | 720,000 |
| 32 | LIVANOVA PLC | $10M | 155,000 |
| 33 | ELEVANCE HEALTH INC | $9M | 32,300 |
| 34 | ARROWHEAD PHARMACEUTICALS IN | $9M | 144,500 |
| 35 | GLAUKOS CORP | $9M | 84,000 |
| 36 | IQVIA HLDGS INC | $9M | 53,000 |
| 37 | SYNDAX PHARMACEUTICALS INC | $9M | 379,250 |
| 38 | MIRUM PHARMACEUTICALS INC | $9M | 92,605 |
| 39 | IDEAYA Biosciences Inc | $9M | 255,500 |
| 40 | PENNANT GROUP INC | $8M | 275,399 |
| 41 | NUVALENT INC | $8M | 81,200 |
| 42 | WAYSTAR HLDG CORP | $8M | 342,566 |
| 43 | ANTERIS TECHNOLOGIES GLOBAL | $8M | 1,438,625 |
| 44 | MEDTRONIC PLC | $8M | 90,000 |
| 45 | OSCAR HEALTH INC | $8M | 660,000 |
| 46 | IOVANCE BIOTHERAPEUTICS INC | $7M | 2,055,327 |
| 47 | MINERALYS THERAPEUTICS INC | $7M | 263,071 |
| 48 | IONIS PHARMACEUTICALS INC | $7M | 92,900 |
| 49 | DIANTHUS THERAPEUTICS INC | $7M | 81,627 |
| 50 | BRIDGEBIO PHARMA INC | $7M | 90,600 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.